BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Amniocentesis
,
Doxorubicin
,
rs7903146
,
DRD2
,
Apoptosis
,
Influenza
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Claudins 18
Summary
General Info
Curated Studies
Most Correlated Studies
HCT-8 colon cancer enterocyte cell response to bacterial signal indole
Lungs of mice with Cldn18 conditional knockout
Breast cancer MDA-MB231 cells xenograft with MFNG shRNA knockdown
Colonic tissues from mice with acute TNBS-induced colitis
Murine metaprofiles associated with human cancer etiology and intrinsic subtypes
Explore Curated Studies Results
Literature
Most Relevant Literature
Claudin-18 Loss Alters Transcellular Chloride Flux but not Tight Junction Ion Selectivity in Gastric…
Claudin 18 turns up the heat in cancer.
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration…
Global Ring Study to Investigate the Comparability of Total Assay Performance of Commercial Claudin …
Claudin-18 status and its correlation with HER2 and PD-L1 expression in gastric cancer with peritone…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenoc…
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advan…
TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Ca…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ